Ebos names US talent to lead medtech brands

Ebos names US talent to lead medtech brands
Andrew McLean brings significant merger and acquisition experience to Ebos, which "aligns well" with the business. (Image: Getty)
Staff reporters
Andrew McLean has been appointed to lead Ebos Group’s medical technology division as the current chief executive, Matt Muscio, transitions into a non-executive director role.McLean will step into the role from Aug 5, 2024 and Muscio will move out from Jan 1, 2025.Most recently based in Boston as the CEO of global medical product manufacturing company SteriPack, McLean has significant mergers and acquisitions experience in the healthcare industry, a key aspect of Ebos’ strategy.Group chief executive John Cullity said McLean&rsqu...